191 related articles for article (PubMed ID: 15587680)
21. Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation.
Shibata E; Powers RW; Rajakumar A; von Versen-Höynck F; Gallaher MJ; Lykins DL; Roberts JM; Hubel CA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1009-16. PubMed ID: 16787961
[TBL] [Abstract][Full Text] [Related]
22. [Regulatory mechanisms for the renin-angiotensin-aldosterone system].
Ichihara A
Nihon Rinsho; 2012 Sep; 70(9):1477-81. PubMed ID: 23012790
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
Paul M; Ganten D
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S51-8. PubMed ID: 1381795
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
25. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
[TBL] [Abstract][Full Text] [Related]
26. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
Ruiz-Ortega M; Esteban V; Egido J
Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
[TBL] [Abstract][Full Text] [Related]
27. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
Kurdi M; De Mello WC; Booz GW
Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
[TBL] [Abstract][Full Text] [Related]
28. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
30. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells.
Ide N; Hirase T; Nishimoto-Hazuku A; Ikeda Y; Node K
Hypertens Res; 2008 Jun; 31(6):1257-67. PubMed ID: 18716376
[TBL] [Abstract][Full Text] [Related]
33. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
34. The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
Kumar R; Singh VP; Baker KM
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):168-73. PubMed ID: 18277150
[TBL] [Abstract][Full Text] [Related]
35. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
36. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
37. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
[TBL] [Abstract][Full Text] [Related]
39. [Renin-angiotensin system and atherosclerosis].
Stajszczyk M; Gmiński J
Postepy Hig Med Dosw; 1993; 47(6):475-85. PubMed ID: 8208630
[TBL] [Abstract][Full Text] [Related]
40. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
